Clinical Trial Update: A Phase 1 Study to Assess HM15275 in Healthy and Obese Subjects. [Phase 1]

View source ↗

Summary

Phase 1 study of HM15275 in healthy and obese subjects has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• HM15275

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Obesity | Phase 1 | Status: COMPLETED